Introduction
Juvenile systemic sclerosis (JSSc) is an autoimmune disease, characterized by disordered collagen accumulation, leading to disseminated vascular lesions in skin and internal organs fibrosis, including the kidneys. [1] [2] [3] Worthy of note, renal involvement is a rare manifestation and occurs in 1-12% of JSSc patients, mainly with arterial hypertension and/or proteinuria. 1, [3] [4] [5] Scleroderma renal crisis was also rarely reported 5, 6 and to our knowledge, nephrotic syndrome (NS) was described in only one JSSc patient with membranous nephropathy. 7 We report herein a patient who presented NS as the first manifestation of JSSc with focal segmental glomerulosclerosis (FSGS).
A female patient presented vomiting, malaise and generalized edema at the age of 12 years. She had systemic arterial hypertension, hypoalbuminemia (<2.5 mg/dL) and proteinuria (urine protein/creatinine ratio ≥2.0 mg/g). She was diagnosed with NS and treated with prednisone (60 mg/m 2 /day) with progressive reduction. During follow-up she had several relapses of NS, one of them associated to the upper respiratory tract infections and another one with spontaneous bacterial peritonitis, and was referred to our University Hospital at the age of 14. On the first admission at our service, she presented orbital and lower limbs edema, systemic arterial hypertension, sclerodactyly and proximal skin sclerosis. revealed serum albumin 0.9 g/dL (normal levels 3.8-5.6), total cholesterol 637 mg/dL (normal <199), low density lipoprotein (LDL) 439 mg/dL (normal <110), serum urea 18 mg/dL (normal 15-45), serum creatinine 0.53 mg/dL (normal 0.6-0.9), 25-hydroxyvitamin D 5 ng/mL (normal 30-100 ng/mL) and proteinuria 7.8 g/day. Hands X-ray revealed no bone abnormalities. Antinuclear antibodies (ANA), rheumatoid factor, and anti-Scl-70 (anti-topoisomerase I), anti-Sm, Anti-SS-A/Ro, Anti-SS-B/La and anti-smooth muscle (anti-SMA) antibodies were negative. C3 and C4 fractions of the complement system were normal. Serology for hepatitis A, B and C, human immunodeficiency virus (HIV), cytomegalovirus, Epstein-Barr virus and syphilis were negative. Echocardiogram was normal. Moderate capillary dilation and mild focal devascularization were observed in nailfold capillaroscopy, compatible with early stage of scleroderma (scleroderma pattern) (Fig. 1) . Percutaneous renal biopsy guided by ultrasound revealed focal segmental glomerulosclerosis and direct immunofluorescence were negative ( Fig. 2A and B) . Therefore, she fullfilled the provisional classification criteria for JSSc. 6 The patient was treated with oral 25-hydroxyvitamin D (800 IU/day), methotrexate (0.5 mg/kg/week) and amlodipin (0.15 mg/kg). Prednisone (60 mg/m 2 /day) was administered for 4 consecutive weeks, followed by alternate-day (40 mg/m 2 ) for 2 consecutive months, with tapering for 4 months and then stopping this medication. Currently, she is being treated with methotrexate 15 mg/week, without edema and proteinuria.
Discussion
To our knowledge, this was the first case reported with steroidsensitive NS and FSGS as the first manifestation of JSSc.
The most important systemic manifestation of JSSc are cutaneous lesions, specially induration proximal to metacarpophalangeal joints, sclerodactly and edema, 1, 3, 4 as observed in the present case. The capillaroscopy can be used to evaluate changes of microcirculation in the capillaries of the nail bed. 8 These findings strongly suggest systemic sclerosis diagnosis, 8 as evidenced herein, and not found in cutaneous scleroderma. 9 Kidney involvement was rarely described in pediatric scleroderma population. The most frequent renal manifestations were arterial hypertension and proteinuria. Renal crisis in JSSc patients ranges from 0.7% to 4%. 1, [3] [4] [5] This is a lifethreatening complication with abrupt onset of malignant arterial hypertension, proteinuria and/or hematuria, thrombotic microangiopathy and potentially can result to end stage kidney disease. 6, 10, 11 Adult scleroderma NS has a great spectrum varying from minimal changes disease and secondary amyloidosis to rapidly progressive renal failure and proliferative changes lesions with crescents, and membranous nephropathy. NS was only reported in one 12-year-old female patient who presented with scleroderma five years after the onset of this renal involvement with membranous nephropathy. 7 Importantly, our patient had steroid sensitive NS with a severe histological pattern of FSGS. This glomerulopathy is an important cause of proteinuria and chronic renal disease in children and adolescents, accounting in 5-15% of all cases of idiopathic NS. 12, 13 The treatment of JSCc is performed according to organs and systems involvement. Methotrexate has been shown to improve skin scores in early diffuse SSc. 14 Additionally, renal treatment of FSGS includes glucocorticoid and antihypertensive drugs, as used in our patient. 12 Interestingly, the absence of proteinuria with complete remission after treatment suggests adequate renal long-term outcome. 13 In conclusion, we reported a rare case of NS with FSGS as the first manifestation of scleroderma. Therefore, renal biopsy is mandatory in JSSc patients with sustained proteinuria or NS.
